RT Journal Article
SR Electronic
T1 Integrating Genetic and Transcriptomic Data to Identify Genes Underlying Obesity Risk Loci
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.11.24308730
DO 10.1101/2024.06.11.24308730
A1 Xu, Hanfei
A1 Gupta, Shreyash
A1 Dinsmore, Ian
A1 Kollu, Abbey
A1 Cawley, Anne Marie
A1 Anwar, Mohammad Y.
A1 Chen, Hung-Hsin
A1 Petty, Lauren E.
A1 Seshadri, Sudha
A1 Graff, Misa
A1 Below, Piper
A1 Brody, Jennifer A.
A1 Chittoor, Geetha
A1 Fisher-Hoch, Susan P.
A1 Heard-Costa, Nancy L.
A1 Levy, Daniel
A1 Lin, Honghuang
A1 Loos, Ruth JF.
A1 Mccormick, Joseph B.
A1 Rotter, Jerome I.
A1 Mirshahi, Tooraj
A1 Still, Christopher D.
A1 Destefano, Anita
A1 Cupples, L. Adrienne
A1 Mohlke, Karen L
A1 North, Kari E.
A1 Justice, Anne E.
A1 Liu, Ching-Ti
YR 2024
UL http://medrxiv.org/content/early/2024/06/12/2024.06.11.24308730.abstract
AB Genome-wide association studies (GWAS) have identified numerous body mass index (BMI) loci. However, most underlying mechanisms from risk locus to BMI remain unknown. Leveraging omics data through integrative analyses could provide more comprehensive views of biological pathways on BMI. We analyzed genotype and blood gene expression data in up to 5,619 samples from the Framingham Heart Study (FHS). Using 3,992 single nucleotide polymorphisms (SNPs) at 97 BMI loci and 20,692 transcripts within 1 Mb, we performed separate association analyses of transcript with BMI and SNP with transcript (PBMI and PSNP, respectively) and then a correlated meta-analysis between the full summary data sets (PMETA). We identified transcripts that met Bonferroni-corrected significance for each omic, were more significant in the correlated meta-analysis than each omic, and were at least nominally associated with BMI in FHS data. Among 308 significant SNP-transcript-BMI associations, we identified seven genes (NT5C2, GSTM3, SNAPC3, SPNS1, TMEM245, YPEL3, and ZNF646) in five association regions. Using an independent sample of blood gene expression data, we validated results for SNAPC3 and YPEL3. We tested for generalization of these associations in hypothalamus, nucleus accumbens, and liver and observed significant (PMETA<0.05 & PMETA<PSNP & PMETA<PBMI) results for YPEL3 in nucleus accumbens and NT5C2, SNAPC3, TMEM245, YPEL3, and ZNF646 in liver. The identified genes help link the genetic variation at obesity risk loci to biological mechanisms and health outcomes, thus translating GWAS findings to function.Competing Interest StatementThe authors have declared no competing interest.Funding StatementIndividual Acknowledgements: SG, ID, GC, CTL, KEN, AEJ, CDS, TM, KLM were funded in part by NIH R01 DK122503. MYA was funded by NIH NIDDK 3R01DK122503.02W1. MG was funded in part by NIH R01HL163262. JIR was funded in part by National Center for Minority Health Disparity (NCMHD), MD000170P20, McCormick. KEN was also funded in part by NIH R01HL142302, R01HL151152, R01 R01HD057194, R01HG010297, and R01HL143885. Study Acknowledgements: The Framingham Heart Study (FHS): The FHS is funded by National Institutes of Health contract N01-HC-25195. The laboratory work for this investigation was funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. The analytical component of this project was funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute, and the Center for Information Technology, National Institutes of Health, Bethesda, MD. The visualization tools and data resources for this project were funded by the National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD. The FHS acknowledges the support of contracts NO1-HC-25195, HHSN268201500001I and 75N92019D00031 from the National Heart, Lung and Blood Institute and grant supplement R01 HL092577-06S1 for this research. We also acknowledge the dedication of the FHS study participants without whom this research would not be possible. This manuscript does not necessarily reflect the opinions or views of the NHLBI, NIH or DHHS. Cameron County Hispanic Community (CCHC) Cohort: We thank our cohort team including the CRU, data and lab staff of the CCHC team. We thank Valley Baptist Medical Center, Brownsville, for providing the space for our Clinical Research Unit. CCHC study and team members were funded by: National Institutes of Health, National Center for Minority Health Disparity, MD000170P20, UL1 TR000371, National Heart, Lung, and Blood Institute, 1R01HL142302, 2R01HL142302, National Center for Advancing Translational Sciences, (NCATS), Clinical and Translational Science Awards (CTSA),UL1 9/30/06-6/30/11, UL1TR0003716/27/12-/31/17, UL1TR0031677/1/19-6/30/2 MyCode Bariatric Surgery Cohort: We thank all the participants of the MyCode Community Health Initiative Study (MyCode) and the MyCode Research Team. We thank the members of the Geisinger-Regeneron DiscovEHR Collaboration who have been critical in the generation of the genetic and transcriptomic data used in this study. This study was funded in part by NIH HL142302, NIH 2R01HL142302, National Center for Advancing Translational Sciences, UL1 9/30/06-6/30/11, UL1TR0003716/27/12-/31/17, UL1TR0031677/1/19-(NCATS), Clinical and Translational Science Awards (CTSA). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Boards of the Boston University Medical Campus and the Geisinger approved the study. The study was approved by the Committee for the Protection of Human Subjects (CPHS) at the University of Texas Health Sciences Center at Houston.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.